Cargando…
Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)—A Case Report
There is limited evidence to guide successful treatment of recurrent Campylobacter infection in patients with common variable immunodeficiency (CVID) already managed on regular immunoglobulin therapy. The role of faecal microbiota transplant (FMT) is uncertain. We report a case of recurrent Campylob...
Autores principales: | Merrick, Blair, Tamilarasan, Aravind Gokul, Luber, Raphael, Yong, Patrick F. K., Cheent, Kuldeep, Irving, Peter M., Meda, Manjula, Goldenberg, Simon D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788277/ https://www.ncbi.nlm.nih.gov/pubmed/35076517 http://dx.doi.org/10.3390/idr14010007 |
Ejemplares similares
-
Modulation of the Gut Microbiota to Control Antimicrobial Resistance (AMR)—A Narrative Review with a Focus on Faecal Microbiota Transplantation (FMT)
por: Merrick, Blair, et al.
Publicado: (2023) -
341. Attitudes and Experiences of Individuals Approached to Participate in a Randomised, Placebo-Controlled, Feasibility Study of Encapsulated Faecal Microbiota Transplantation (FMT) for the Eradication of Gastrointestinal (GI) Carriage of Antibiotic Resistant Organisms (ARO): a Nested Qualitative Study
por: Merrick, Blair, et al.
Publicado: (2023) -
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey
por: Baunwall, Simon Mark Dahl, et al.
Publicado: (2021) -
Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)
por: El-Salhy, Magdy, et al.
Publicado: (2019) -
Faecal microbiota transplantation (FMT) with dietary therapy for acute severe ulcerative colitis
por: Costello, Samuel Paul, et al.
Publicado: (2020)